Ad
For the contract with AstraZeneca, the European Commission has allocated €336m - although not all of it has been paid yet (Photo: Cheshire East Council)

EU-AstraZeneca row flares up after vaccines shortfall

The EU's standoff with vaccine-manufacturer AstraZeneca has intensified, after the company's CEO said the contract signed with the European Commission is on a "best-effort" basis - meaning that there is no legal obligation to fulfil the order set up by the EU for the first quarter.

In response, the EU is urging AstraZeneca to make their vaccine contract public in order to "open the debate," arguing that confidentiality clauses of the contract forbid them to talk about the issues in deta...

Get EU news that matters

Back our independent journalism by becoming a supporting member

Already a member? Login here

Author Bio

Elena is EUobserver's Managing Editor. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.

For the contract with AstraZeneca, the European Commission has allocated €336m - although not all of it has been paid yet (Photo: Cheshire East Council)

Tags

Author Bio

Elena is EUobserver's Managing Editor. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.

Ad

Related articles

Ad
Ad